动态PD-L1调节塑造瘤免疫逃生和对免疫治疗的反应
Bruce Pell1, Aigerim Kalizhanova2, Aisha Tursynkozha3
1Department of Mathematics and Computer Science, Lawrence Technological University, Southfield, MI 48075, USA.
Cancers
|December 11, 2025
概括
瘤细胞通过PD-1/PD-L1免疫逃生逃避癌症免疫治疗. 这项研究模拟了Avelumab和NHS-muIL12联合治疗如何影响PD-L1动态,揭示了治疗成功和失败的机制.
科学领域:
- 计算生物学 计算生物学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 癌症免疫疗法面临的挑战是由于瘤细胞的免疫逃脱,通常涉及PD-1/PD-L1通路.
- 了解适应性耐药机制对于改善组合疗法的疗效至关重要.
研究的目的:
- 开发和验证组合免疫疗法 (Avelumab + NHS-muIL12) 的机械数学模型.
- 研究动态PD-L1表达在调解治疗协同作用和治疗失败中的作用.
主要方法:
- 调整了一个普通微分方程模型,以纳入Avelumab和NHS-muIL12动态.
- 被治疗的PD-L1瘤表达是通过治疗调节的动态变量 (ε).
- 使用独立的EMT-6和MC38癌症数据集验证了该模型.
主要成果:
- 该模型通过调整瘤特异性参数和PD-L1动态,成功地在不同癌症数据集中复制了不同的结果.
- 在NHS-muIL12治疗后,动态PD-L1上调被确定为瘤耐药性的关键机制.
- 结合治疗中的PD-1/PD-L1阻断被证明可以促进有效的抗瘤免疫反应.
结论:
- 在组合免疫疗法中建立了适应性耐药性的验证机制框架.
- 响应者和非响应者表型之间的量化差异可以为预测工具的开发提供信息.
- 该框架通过了解免疫逃生动态来支持优化癌症治疗策略.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K


